跳至主要内容
临床试验/NCT01554280
NCT01554280已完成不适用

Fully, Coated, Removable, Self-expanding Oesophageal Stents for the Prevention of Oesophageal Stricture Following Endoscopic Mucosal Resection of Short Segment Barrett's With High Grade Dysplasia and Early Cancer.

Professor Michael Bourke2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Improvement in Stricture Formation

研究概览

简要总结

The purpose of this study is to investigate whether preventative placement of a removable oesophageal stent reduces the rate of scar tissue, or stricture formation after removing the precancerous or early cancerous Barrett's mucosa by Endoscopic Mucosal Resection (EMR). The stent will be placed 10-14 days after initial EMR. The stent will then be removed 8 weeks later by repeat Endoscopy. Patients will be followed up weekly following insertion of the oesophageal stent.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with short segment Barrett's Oesophagus with high grade dysplasia or early cancer, having circumferential EMR to achieve complete Barrett's excision.
  • Aged 18-75 years old
  • Biopsy proven to be Barretts with HGD or EAC
  • The absence or lymph node involvement
  • Short segment <3cm of Barretts Oesophagus.

排除标准

  • Women who are pregnant and the human foetus
  • Children and/or young people <18 years
  • People with an intellectual or mental impairment.

结局指标

主要结局

Improvement in Stricture Formation

时间窗: 12 weeks

Initial evaluation of Dysphagia score which is used to assess the stricture formation prior to EMR. Followed by weekly phone calls to assess ability to swallow liquids and food.

次要结局

未报告次要终点

研究者

发起方
Professor Michael Bourke
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Professor Michael Bourke

Dr Michael Bourke

Western Sydney Local Health District

研究点 (2)

Loading locations...

相似试验